Competent Cells Market by Type (Electrocompetent, Chemically), Application (Phage Display Library Production, Subcloning, High-Throughput Cloning, Unstable DNA Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: June 2, 2019
Clear
SKU: GMS823 Category:

The competent cell market is expected to rise at 9.6% CAGR to USD 3.43 billion in 2024. Advances in molecular cloning research due to the emergence of new technologies and growing commercial demand for molecular cloned products and recombinant proteins are key factors driving the growth of the market for competent cells.

Competent Cells Market by Type (Electrocompetent, Chemically), Application (Phage Display Library Production, Subcloning, High-Throughput Cloning, Unstable DNA Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) - 2019 to 2024 1

Competent Cells Market by Type (Electrocompetent, Chemically), Application (Phage Display Library Production, Subcloning, High-Throughput Cloning, Unstable DNA Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) - 2019 to 2024 2

Competent Cells Market by Type (Electrocompetent, Chemically), Application (Phage Display Library Production, Subcloning, High-Throughput Cloning, Unstable DNA Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) - 2019 to 2024 3

Competent Cells Market by Type (Electrocompetent, Chemically), Application (Phage Display Library Production, Subcloning, High-Throughput Cloning, Unstable DNA Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) - 2019 to 2024 4

Competent Cells Market by Type (Electrocompetent, Chemically), Application (Phage Display Library Production, Subcloning, High-Throughput Cloning, Unstable DNA Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) - 2019 to 2024 5

Competent Cells Market by Type (Electrocompetent, Chemically), Application (Phage Display Library Production, Subcloning, High-Throughput Cloning, Unstable DNA Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) - 2019 to 2024 6

Competent Cells Market by Type (Electrocompetent, Chemically), Application (Phage Display Library Production, Subcloning, High-Throughput Cloning, Unstable DNA Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) - 2019 to 2024 7

Competent Cells Market by Type (Electrocompetent, Chemically), Application (Phage Display Library Production, Subcloning, High-Throughput Cloning, Unstable DNA Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) - 2019 to 2024 8

1 Global Competent Cells Market 
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Competent Cells Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Competent Cells Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Competent Cells Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Competent Cells Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Competent Cells Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Competent Cells Market – By Type (Market Size – & million/billion)
8.1 Chemically Competent Cells
8.2 Electrocompetent Cells

9 Global Competent Cells Market – By Application
9.1 Cloning
9.2 Protein Expression
9.3 Other

10 Global Competent Cells Market – By End-User
10.1 Pharmaceutical and Biotechnology Companies
10.2 Academic Research Institutes
10.3 Contract Research Organizations (CROs)

11 Global Competent Cells Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Competent Cells Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Competent Cells Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Thermo Fisher Scientific, Inc.
13.3 Merck KGaA
13.4 Promega Corporation
13.5 Bio-Rad Laboratories, Inc.
13.6 Takara Bio, Inc.
13.7 Illumina, Inc.
13.8 Qiagen N.V.
13.9 New England Biolabs, Inc.
13.10 Transgen Biotech, Inc.
13.11 Agilent Technologies, Inc.
13.12 Company 11 & more

14 Global Competent Cells Market – Appendix
14.1 Sources
14.2 Abbreviations